InvestorEmpowering Arizona's startups through innovation and funding.

Hatch Biofund Management is an early-stage venture capital firm focused on life sciences, based in the Philadelphia region. It invests in private companies developing therapeutics and vaccines, leveraging its ties to the Pennsylvania Biotechnology Center.
Online destinations
Where to find this organization online, grouped by who runs each page. A link here does not mean the organization controls it.
Pages the organization runs itself.
Hatch Biofund Management is a life sciences venture capital firm headquartered in the Philadelphia region, launched in 2023 as the investment arm of the Pennsylvania Biotechnology Center (PABC). The firm aims to provide early-stage capital to promising life science companies, along with access to industry expertise and physical platforms to support their missions. Hatch Biofund exclusively invests in private companies developing therapeutics and vaccines for human use, favoring capital efficiency and clear development pathways. Its deal flow is primarily driven by the PABC incubator and B+labs, focusing on early-stage investments in the biotech sector.
Hatch Biofund exclusively invests in private companies that are innovating in the fields of therapeutics and vaccines. The firm is particularly interested in capital-efficient projects with a clear understanding of disease biology and development pathways that promise significant societal value. It invests across all development stages, including seed and Series A rounds.
Hatch Biofund adds value to its portfolio companies by providing not only capital but also access to physical lab space, incubation infrastructure, and deep industry expertise through its connections with the Pennsylvania Biotechnology Center and other partners.
Superscout Pro
Is this page right?Reviewed · How the research works